Global Travelers Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Travelers Vaccines market size was valued at US$ 3791 million in 2024 and is forecast to a readjusted size of USD 6709 million by 2031 with a CAGR of 8.6% during review period.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
This report is a detailed and comprehensive analysis for global Travelers Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End Users. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Travelers Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market size and forecasts, by Type and by End Users, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Travelers Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Travelers Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Travelers Vaccines market is split by Type and by End Users. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Travelers Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales quantity, revenue, and global market share of Travelers Vaccines from 2020 to 2025.
Chapter 3, the Travelers Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by End Users, with sales market share and growth rate by Type, by End Users, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Travelers Vaccines market forecast, by regions, by Type, and by End Users, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccines.
Chapter 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
This report is a detailed and comprehensive analysis for global Travelers Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End Users. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Travelers Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market size and forecasts, by Type and by End Users, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (USD/Dose), 2020-2031
Global Travelers Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (USD/Dose), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Travelers Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Travelers Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Travelers Vaccines market is split by Type and by End Users. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End Users in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Yellow Fever Vaccine
- Hepatitis Vaccine
- Cholera Vaccine
- Other
- Tourists
- Students
- Workers
- Others
- GlaxoSmithKline
- Sanofi Pasteur
- Merck
- Pfizer
- CNBG
- Sanofi Pasteur MSD
- Serum Institute of India
- Biokangtai
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Travelers Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Travelers Vaccines, with price, sales quantity, revenue, and global market share of Travelers Vaccines from 2020 to 2025.
Chapter 3, the Travelers Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Travelers Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by End Users, with sales market share and growth rate by Type, by End Users, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Travelers Vaccines market forecast, by regions, by Type, and by End Users, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Travelers Vaccines.
Chapter 14 and 15, to describe Travelers Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Travelers Vaccines Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Meningococcal Vaccine
1.3.3 Japanese Encephalitis Vaccine
1.3.4 Yellow Fever Vaccine
1.3.5 Hepatitis Vaccine
1.3.6 Cholera Vaccine
1.3.7 Other
1.4 Market Analysis by End Users
1.4.1 Overview: Global Travelers Vaccines Consumption Value by End Users: 2020 Versus 2024 Versus 2031
1.4.2 Tourists
1.4.3 Students
1.4.4 Workers
1.4.5 Others
1.5 Global Travelers Vaccines Market Size & Forecast
1.5.1 Global Travelers Vaccines Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Travelers Vaccines Sales Quantity (2020-2031)
1.5.3 Global Travelers Vaccines Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Travelers Vaccines Product and Services
2.1.4 GlaxoSmithKline Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Travelers Vaccines Product and Services
2.2.4 Sanofi Pasteur Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Travelers Vaccines Product and Services
2.3.4 Merck Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Travelers Vaccines Product and Services
2.4.4 Pfizer Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Pfizer Recent Developments/Updates
2.5 CNBG
2.5.1 CNBG Details
2.5.2 CNBG Major Business
2.5.3 CNBG Travelers Vaccines Product and Services
2.5.4 CNBG Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 CNBG Recent Developments/Updates
2.6 Sanofi Pasteur MSD
2.6.1 Sanofi Pasteur MSD Details
2.6.2 Sanofi Pasteur MSD Major Business
2.6.3 Sanofi Pasteur MSD Travelers Vaccines Product and Services
2.6.4 Sanofi Pasteur MSD Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sanofi Pasteur MSD Recent Developments/Updates
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Travelers Vaccines Product and Services
2.7.4 Serum Institute of India Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Serum Institute of India Recent Developments/Updates
2.8 Biokangtai
2.8.1 Biokangtai Details
2.8.2 Biokangtai Major Business
2.8.3 Biokangtai Travelers Vaccines Product and Services
2.8.4 Biokangtai Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Biokangtai Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TRAVELERS VACCINES BY MANUFACTURER
3.1 Global Travelers Vaccines Sales Quantity by Manufacturer (2020-2025)
3.2 Global Travelers Vaccines Revenue by Manufacturer (2020-2025)
3.3 Global Travelers Vaccines Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Travelers Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Travelers Vaccines Manufacturer Market Share in 2024
3.4.3 Top 6 Travelers Vaccines Manufacturer Market Share in 2024
3.5 Travelers Vaccines Market: Overall Company Footprint Analysis
3.5.1 Travelers Vaccines Market: Region Footprint
3.5.2 Travelers Vaccines Market: Company Product Type Footprint
3.5.3 Travelers Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Travelers Vaccines Market Size by Region
4.1.1 Global Travelers Vaccines Sales Quantity by Region (2020-2031)
4.1.2 Global Travelers Vaccines Consumption Value by Region (2020-2031)
4.1.3 Global Travelers Vaccines Average Price by Region (2020-2031)
4.2 North America Travelers Vaccines Consumption Value (2020-2031)
4.3 Europe Travelers Vaccines Consumption Value (2020-2031)
4.4 Asia-Pacific Travelers Vaccines Consumption Value (2020-2031)
4.5 South America Travelers Vaccines Consumption Value (2020-2031)
4.6 Middle East & Africa Travelers Vaccines Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Travelers Vaccines Sales Quantity by Type (2020-2031)
5.2 Global Travelers Vaccines Consumption Value by Type (2020-2031)
5.3 Global Travelers Vaccines Average Price by Type (2020-2031)
6 MARKET SEGMENT BY END USERS
6.1 Global Travelers Vaccines Sales Quantity by End Users (2020-2031)
6.2 Global Travelers Vaccines Consumption Value by End Users (2020-2031)
6.3 Global Travelers Vaccines Average Price by End Users (2020-2031)
7 NORTH AMERICA
7.1 North America Travelers Vaccines Sales Quantity by Type (2020-2031)
7.2 North America Travelers Vaccines Sales Quantity by End Users (2020-2031)
7.3 North America Travelers Vaccines Market Size by Country
7.3.1 North America Travelers Vaccines Sales Quantity by Country (2020-2031)
7.3.2 North America Travelers Vaccines Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Travelers Vaccines Sales Quantity by Type (2020-2031)
8.2 Europe Travelers Vaccines Sales Quantity by End Users (2020-2031)
8.3 Europe Travelers Vaccines Market Size by Country
8.3.1 Europe Travelers Vaccines Sales Quantity by Country (2020-2031)
8.3.2 Europe Travelers Vaccines Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Travelers Vaccines Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2020-2031)
9.3 Asia-Pacific Travelers Vaccines Market Size by Region
9.3.1 Asia-Pacific Travelers Vaccines Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Travelers Vaccines Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Travelers Vaccines Sales Quantity by Type (2020-2031)
10.2 South America Travelers Vaccines Sales Quantity by End Users (2020-2031)
10.3 South America Travelers Vaccines Market Size by Country
10.3.1 South America Travelers Vaccines Sales Quantity by Country (2020-2031)
10.3.2 South America Travelers Vaccines Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Travelers Vaccines Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2020-2031)
11.3 Middle East & Africa Travelers Vaccines Market Size by Country
11.3.1 Middle East & Africa Travelers Vaccines Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Travelers Vaccines Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Travelers Vaccines Market Drivers
12.2 Travelers Vaccines Market Restraints
12.3 Travelers Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Travelers Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Travelers Vaccines
13.3 Travelers Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Travelers Vaccines Typical Distributors
14.3 Travelers Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Travelers Vaccines Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Meningococcal Vaccine
1.3.3 Japanese Encephalitis Vaccine
1.3.4 Yellow Fever Vaccine
1.3.5 Hepatitis Vaccine
1.3.6 Cholera Vaccine
1.3.7 Other
1.4 Market Analysis by End Users
1.4.1 Overview: Global Travelers Vaccines Consumption Value by End Users: 2020 Versus 2024 Versus 2031
1.4.2 Tourists
1.4.3 Students
1.4.4 Workers
1.4.5 Others
1.5 Global Travelers Vaccines Market Size & Forecast
1.5.1 Global Travelers Vaccines Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Travelers Vaccines Sales Quantity (2020-2031)
1.5.3 Global Travelers Vaccines Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Travelers Vaccines Product and Services
2.1.4 GlaxoSmithKline Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Travelers Vaccines Product and Services
2.2.4 Sanofi Pasteur Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Sanofi Pasteur Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Travelers Vaccines Product and Services
2.3.4 Merck Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Merck Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Travelers Vaccines Product and Services
2.4.4 Pfizer Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Pfizer Recent Developments/Updates
2.5 CNBG
2.5.1 CNBG Details
2.5.2 CNBG Major Business
2.5.3 CNBG Travelers Vaccines Product and Services
2.5.4 CNBG Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 CNBG Recent Developments/Updates
2.6 Sanofi Pasteur MSD
2.6.1 Sanofi Pasteur MSD Details
2.6.2 Sanofi Pasteur MSD Major Business
2.6.3 Sanofi Pasteur MSD Travelers Vaccines Product and Services
2.6.4 Sanofi Pasteur MSD Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sanofi Pasteur MSD Recent Developments/Updates
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Travelers Vaccines Product and Services
2.7.4 Serum Institute of India Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Serum Institute of India Recent Developments/Updates
2.8 Biokangtai
2.8.1 Biokangtai Details
2.8.2 Biokangtai Major Business
2.8.3 Biokangtai Travelers Vaccines Product and Services
2.8.4 Biokangtai Travelers Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Biokangtai Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TRAVELERS VACCINES BY MANUFACTURER
3.1 Global Travelers Vaccines Sales Quantity by Manufacturer (2020-2025)
3.2 Global Travelers Vaccines Revenue by Manufacturer (2020-2025)
3.3 Global Travelers Vaccines Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Travelers Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Travelers Vaccines Manufacturer Market Share in 2024
3.4.3 Top 6 Travelers Vaccines Manufacturer Market Share in 2024
3.5 Travelers Vaccines Market: Overall Company Footprint Analysis
3.5.1 Travelers Vaccines Market: Region Footprint
3.5.2 Travelers Vaccines Market: Company Product Type Footprint
3.5.3 Travelers Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Travelers Vaccines Market Size by Region
4.1.1 Global Travelers Vaccines Sales Quantity by Region (2020-2031)
4.1.2 Global Travelers Vaccines Consumption Value by Region (2020-2031)
4.1.3 Global Travelers Vaccines Average Price by Region (2020-2031)
4.2 North America Travelers Vaccines Consumption Value (2020-2031)
4.3 Europe Travelers Vaccines Consumption Value (2020-2031)
4.4 Asia-Pacific Travelers Vaccines Consumption Value (2020-2031)
4.5 South America Travelers Vaccines Consumption Value (2020-2031)
4.6 Middle East & Africa Travelers Vaccines Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Travelers Vaccines Sales Quantity by Type (2020-2031)
5.2 Global Travelers Vaccines Consumption Value by Type (2020-2031)
5.3 Global Travelers Vaccines Average Price by Type (2020-2031)
6 MARKET SEGMENT BY END USERS
6.1 Global Travelers Vaccines Sales Quantity by End Users (2020-2031)
6.2 Global Travelers Vaccines Consumption Value by End Users (2020-2031)
6.3 Global Travelers Vaccines Average Price by End Users (2020-2031)
7 NORTH AMERICA
7.1 North America Travelers Vaccines Sales Quantity by Type (2020-2031)
7.2 North America Travelers Vaccines Sales Quantity by End Users (2020-2031)
7.3 North America Travelers Vaccines Market Size by Country
7.3.1 North America Travelers Vaccines Sales Quantity by Country (2020-2031)
7.3.2 North America Travelers Vaccines Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Travelers Vaccines Sales Quantity by Type (2020-2031)
8.2 Europe Travelers Vaccines Sales Quantity by End Users (2020-2031)
8.3 Europe Travelers Vaccines Market Size by Country
8.3.1 Europe Travelers Vaccines Sales Quantity by Country (2020-2031)
8.3.2 Europe Travelers Vaccines Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Travelers Vaccines Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Travelers Vaccines Sales Quantity by End Users (2020-2031)
9.3 Asia-Pacific Travelers Vaccines Market Size by Region
9.3.1 Asia-Pacific Travelers Vaccines Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Travelers Vaccines Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Travelers Vaccines Sales Quantity by Type (2020-2031)
10.2 South America Travelers Vaccines Sales Quantity by End Users (2020-2031)
10.3 South America Travelers Vaccines Market Size by Country
10.3.1 South America Travelers Vaccines Sales Quantity by Country (2020-2031)
10.3.2 South America Travelers Vaccines Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Travelers Vaccines Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Travelers Vaccines Sales Quantity by End Users (2020-2031)
11.3 Middle East & Africa Travelers Vaccines Market Size by Country
11.3.1 Middle East & Africa Travelers Vaccines Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Travelers Vaccines Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Travelers Vaccines Market Drivers
12.2 Travelers Vaccines Market Restraints
12.3 Travelers Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Travelers Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Travelers Vaccines
13.3 Travelers Vaccines Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Travelers Vaccines Typical Distributors
14.3 Travelers Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. GlobalTravelers Vaccines Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. GlobalTravelers Vaccines Consumption Value by End Users, (USD Million), 2020 & 2024 & 2031
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKlineTravelers Vaccines Product and Services
Table 6. GlaxoSmithKlineTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi PasteurTravelers Vaccines Product and Services
Table 11. Sanofi PasteurTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. MerckTravelers Vaccines Product and Services
Table 16. MerckTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. PfizerTravelers Vaccines Product and Services
Table 21. PfizerTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Pfizer Recent Developments/Updates
Table 23. CNBG Basic Information, Manufacturing Base and Competitors
Table 24. CNBG Major Business
Table 25. CNBGTravelers Vaccines Product and Services
Table 26. CNBGTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. CNBG Recent Developments/Updates
Table 28. Sanofi Pasteur MSD Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Pasteur MSD Major Business
Table 30. Sanofi Pasteur MSDTravelers Vaccines Product and Services
Table 31. Sanofi Pasteur MSDTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Sanofi Pasteur MSD Recent Developments/Updates
Table 33. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 34. Serum Institute of India Major Business
Table 35. Serum Institute of IndiaTravelers Vaccines Product and Services
Table 36. Serum Institute of IndiaTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Serum Institute of India Recent Developments/Updates
Table 38. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 39. Biokangtai Major Business
Table 40. BiokangtaiTravelers Vaccines Product and Services
Table 41. BiokangtaiTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Biokangtai Recent Developments/Updates
Table 43. GlobalTravelers Vaccines Sales Quantity by Manufacturer (2020-2025) & (K Doses)
Table 44. GlobalTravelers Vaccines Revenue by Manufacturer (2020-2025) & (USD Million)
Table 45. GlobalTravelers Vaccines Average Price by Manufacturer (2020-2025) & (USD/Dose)
Table 46. Market Position of Manufacturers inTravelers Vaccines, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 47. Head Office andTravelers Vaccines Production Site of Key Manufacturer
Table 48.Travelers Vaccines Market: Company ProductTypeFootprint
Table 49.Travelers Vaccines Market: Company Product ApplicationFootprint
Table 50.Travelers Vaccines New Market Entrants and Barriers to Market Entry
Table 51.Travelers Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. GlobalTravelers Vaccines Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 53. GlobalTravelers Vaccines Sales Quantity by Region (2020-2025) & (K Doses)
Table 54. GlobalTravelers Vaccines Sales Quantity by Region (2026-2031) & (K Doses)
Table 55. GlobalTravelers Vaccines Consumption Value by Region (2020-2025) & (USD Million)
Table 56. GlobalTravelers Vaccines Consumption Value by Region (2026-2031) & (USD Million)
Table 57. GlobalTravelers Vaccines Average Price by Region (2020-2025) & (USD/Dose)
Table 58. GlobalTravelers Vaccines Average Price by Region (2026-2031) & (USD/Dose)
Table 59. GlobalTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 60. GlobalTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 61. GlobalTravelers Vaccines Consumption Value byType (2020-2025) & (USD Million)
Table 62. GlobalTravelers Vaccines Consumption Value byType (2026-2031) & (USD Million)
Table 63. GlobalTravelers Vaccines Average Price byType (2020-2025) & (USD/Dose)
Table 64. GlobalTravelers Vaccines Average Price byType (2026-2031) & (USD/Dose)
Table 65. GlobalTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 66. GlobalTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 67. GlobalTravelers Vaccines Consumption Value by End Users (2020-2025) & (USD Million)
Table 68. GlobalTravelers Vaccines Consumption Value by End Users (2026-2031) & (USD Million)
Table 69. GlobalTravelers Vaccines Average Price by End Users (2020-2025) & (USD/Dose)
Table 70. GlobalTravelers Vaccines Average Price by End Users (2026-2031) & (USD/Dose)
Table 71. North AmericaTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 72. North AmericaTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 73. North AmericaTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 74. North AmericaTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 75. North AmericaTravelers Vaccines Sales Quantity by Country (2020-2025) & (K Doses)
Table 76. North AmericaTravelers Vaccines Sales Quantity by Country (2026-2031) & (K Doses)
Table 77. North AmericaTravelers Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North AmericaTravelers Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 79. EuropeTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 80. EuropeTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 81. EuropeTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 82. EuropeTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 83. EuropeTravelers Vaccines Sales Quantity by Country (2020-2025) & (K Doses)
Table 84. EuropeTravelers Vaccines Sales Quantity by Country (2026-2031) & (K Doses)
Table 85. EuropeTravelers Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 86. EuropeTravelers Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Asia-PacificTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 88. Asia-PacificTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 89. Asia-PacificTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 90. Asia-PacificTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 91. Asia-PacificTravelers Vaccines Sales Quantity by Region (2020-2025) & (K Doses)
Table 92. Asia-PacificTravelers Vaccines Sales Quantity by Region (2026-2031) & (K Doses)
Table 93. Asia-PacificTravelers Vaccines Consumption Value by Region (2020-2025) & (USD Million)
Table 94. Asia-PacificTravelers Vaccines Consumption Value by Region (2026-2031) & (USD Million)
Table 95. South AmericaTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 96. South AmericaTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 97. South AmericaTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 98. South AmericaTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 99. South AmericaTravelers Vaccines Sales Quantity by Country (2020-2025) & (K Doses)
Table 100. South AmericaTravelers Vaccines Sales Quantity by Country (2026-2031) & (K Doses)
Table 101. South AmericaTravelers Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 102. South AmericaTravelers Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Middle East & AfricaTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 104. Middle East & AfricaTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 105. Middle East & AfricaTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 106. Middle East & AfricaTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 107. Middle East & AfricaTravelers Vaccines Sales Quantity by Country (2020-2025) & (K Doses)
Table 108. Middle East & AfricaTravelers Vaccines Sales Quantity by Country (2026-2031) & (K Doses)
Table 109. Middle East & AfricaTravelers Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 110. Middle East & AfricaTravelers Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 111.Travelers Vaccines Raw Material
Table 112. Key Manufacturers ofTravelers Vaccines Raw Materials
Table 113.Travelers VaccinesTypical Distributors
Table 114.Travelers VaccinesTypical Customers
Table 1. GlobalTravelers Vaccines Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. GlobalTravelers Vaccines Consumption Value by End Users, (USD Million), 2020 & 2024 & 2031
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKlineTravelers Vaccines Product and Services
Table 6. GlaxoSmithKlineTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Pasteur Major Business
Table 10. Sanofi PasteurTravelers Vaccines Product and Services
Table 11. Sanofi PasteurTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Sanofi Pasteur Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. MerckTravelers Vaccines Product and Services
Table 16. MerckTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Merck Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. PfizerTravelers Vaccines Product and Services
Table 21. PfizerTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Pfizer Recent Developments/Updates
Table 23. CNBG Basic Information, Manufacturing Base and Competitors
Table 24. CNBG Major Business
Table 25. CNBGTravelers Vaccines Product and Services
Table 26. CNBGTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. CNBG Recent Developments/Updates
Table 28. Sanofi Pasteur MSD Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Pasteur MSD Major Business
Table 30. Sanofi Pasteur MSDTravelers Vaccines Product and Services
Table 31. Sanofi Pasteur MSDTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Sanofi Pasteur MSD Recent Developments/Updates
Table 33. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 34. Serum Institute of India Major Business
Table 35. Serum Institute of IndiaTravelers Vaccines Product and Services
Table 36. Serum Institute of IndiaTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Serum Institute of India Recent Developments/Updates
Table 38. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 39. Biokangtai Major Business
Table 40. BiokangtaiTravelers Vaccines Product and Services
Table 41. BiokangtaiTravelers Vaccines Sales Quantity (K Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Biokangtai Recent Developments/Updates
Table 43. GlobalTravelers Vaccines Sales Quantity by Manufacturer (2020-2025) & (K Doses)
Table 44. GlobalTravelers Vaccines Revenue by Manufacturer (2020-2025) & (USD Million)
Table 45. GlobalTravelers Vaccines Average Price by Manufacturer (2020-2025) & (USD/Dose)
Table 46. Market Position of Manufacturers inTravelers Vaccines, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 47. Head Office andTravelers Vaccines Production Site of Key Manufacturer
Table 48.Travelers Vaccines Market: Company ProductTypeFootprint
Table 49.Travelers Vaccines Market: Company Product ApplicationFootprint
Table 50.Travelers Vaccines New Market Entrants and Barriers to Market Entry
Table 51.Travelers Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 52. GlobalTravelers Vaccines Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 53. GlobalTravelers Vaccines Sales Quantity by Region (2020-2025) & (K Doses)
Table 54. GlobalTravelers Vaccines Sales Quantity by Region (2026-2031) & (K Doses)
Table 55. GlobalTravelers Vaccines Consumption Value by Region (2020-2025) & (USD Million)
Table 56. GlobalTravelers Vaccines Consumption Value by Region (2026-2031) & (USD Million)
Table 57. GlobalTravelers Vaccines Average Price by Region (2020-2025) & (USD/Dose)
Table 58. GlobalTravelers Vaccines Average Price by Region (2026-2031) & (USD/Dose)
Table 59. GlobalTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 60. GlobalTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 61. GlobalTravelers Vaccines Consumption Value byType (2020-2025) & (USD Million)
Table 62. GlobalTravelers Vaccines Consumption Value byType (2026-2031) & (USD Million)
Table 63. GlobalTravelers Vaccines Average Price byType (2020-2025) & (USD/Dose)
Table 64. GlobalTravelers Vaccines Average Price byType (2026-2031) & (USD/Dose)
Table 65. GlobalTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 66. GlobalTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 67. GlobalTravelers Vaccines Consumption Value by End Users (2020-2025) & (USD Million)
Table 68. GlobalTravelers Vaccines Consumption Value by End Users (2026-2031) & (USD Million)
Table 69. GlobalTravelers Vaccines Average Price by End Users (2020-2025) & (USD/Dose)
Table 70. GlobalTravelers Vaccines Average Price by End Users (2026-2031) & (USD/Dose)
Table 71. North AmericaTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 72. North AmericaTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 73. North AmericaTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 74. North AmericaTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 75. North AmericaTravelers Vaccines Sales Quantity by Country (2020-2025) & (K Doses)
Table 76. North AmericaTravelers Vaccines Sales Quantity by Country (2026-2031) & (K Doses)
Table 77. North AmericaTravelers Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North AmericaTravelers Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 79. EuropeTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 80. EuropeTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 81. EuropeTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 82. EuropeTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 83. EuropeTravelers Vaccines Sales Quantity by Country (2020-2025) & (K Doses)
Table 84. EuropeTravelers Vaccines Sales Quantity by Country (2026-2031) & (K Doses)
Table 85. EuropeTravelers Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 86. EuropeTravelers Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Asia-PacificTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 88. Asia-PacificTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 89. Asia-PacificTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 90. Asia-PacificTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 91. Asia-PacificTravelers Vaccines Sales Quantity by Region (2020-2025) & (K Doses)
Table 92. Asia-PacificTravelers Vaccines Sales Quantity by Region (2026-2031) & (K Doses)
Table 93. Asia-PacificTravelers Vaccines Consumption Value by Region (2020-2025) & (USD Million)
Table 94. Asia-PacificTravelers Vaccines Consumption Value by Region (2026-2031) & (USD Million)
Table 95. South AmericaTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 96. South AmericaTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 97. South AmericaTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 98. South AmericaTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 99. South AmericaTravelers Vaccines Sales Quantity by Country (2020-2025) & (K Doses)
Table 100. South AmericaTravelers Vaccines Sales Quantity by Country (2026-2031) & (K Doses)
Table 101. South AmericaTravelers Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 102. South AmericaTravelers Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Middle East & AfricaTravelers Vaccines Sales Quantity byType (2020-2025) & (K Doses)
Table 104. Middle East & AfricaTravelers Vaccines Sales Quantity byType (2026-2031) & (K Doses)
Table 105. Middle East & AfricaTravelers Vaccines Sales Quantity by End Users (2020-2025) & (K Doses)
Table 106. Middle East & AfricaTravelers Vaccines Sales Quantity by End Users (2026-2031) & (K Doses)
Table 107. Middle East & AfricaTravelers Vaccines Sales Quantity by Country (2020-2025) & (K Doses)
Table 108. Middle East & AfricaTravelers Vaccines Sales Quantity by Country (2026-2031) & (K Doses)
Table 109. Middle East & AfricaTravelers Vaccines Consumption Value by Country (2020-2025) & (USD Million)
Table 110. Middle East & AfricaTravelers Vaccines Consumption Value by Country (2026-2031) & (USD Million)
Table 111.Travelers Vaccines Raw Material
Table 112. Key Manufacturers ofTravelers Vaccines Raw Materials
Table 113.Travelers VaccinesTypical Distributors
Table 114.Travelers VaccinesTypical Customers
LIST OF FIGURES
Figure 1.Travelers Vaccines Picture
Figure 2. GlobalTravelers Vaccines Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. GlobalTravelers Vaccines Revenue Market Share byType in 2024
Figure 4. Meningococcal Vaccine Examples
Figure 5. Japanese Encephalitis Vaccine Examples
Figure 6. YellowFever Vaccine Examples
Figure 7. Hepatitis Vaccine Examples
Figure 8. Cholera Vaccine Examples
Figure 9. Other Examples
Figure 10. GlobalTravelers Vaccines Consumption Value by End Users, (USD Million), 2020 & 2024 & 2031
Figure 11. GlobalTravelers Vaccines Revenue Market Share by End Users in 2024
Figure 12.Tourists Examples
Figure 13. Students Examples
Figure 14. Workers Examples
Figure 15. Others Examples
Figure 16. GlobalTravelers Vaccines Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 17. GlobalTravelers Vaccines Consumption Value andForecast (2020-2031) & (USD Million)
Figure 18. GlobalTravelers Vaccines Sales Quantity (2020-2031) & (K Doses)
Figure 19. GlobalTravelers Vaccines Price (2020-2031) & (USD/Dose)
Figure 20. GlobalTravelers Vaccines Sales Quantity Market Share by Manufacturer in 2024
Figure 21. GlobalTravelers Vaccines Revenue Market Share by Manufacturer in 2024
Figure 22. Producer Shipments ofTravelers Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 23.Top 3Travelers Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 24.Top 6Travelers Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 25. GlobalTravelers Vaccines Sales Quantity Market Share by Region (2020-2031)
Figure 26. GlobalTravelers Vaccines Consumption Value Market Share by Region (2020-2031)
Figure 27. North AmericaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 28. EuropeTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 29. Asia-PacificTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 30. South AmericaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 31. Middle East & AfricaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 32. GlobalTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 33. GlobalTravelers Vaccines Consumption Value Market Share byType (2020-2031)
Figure 34. GlobalTravelers Vaccines Average Price byType (2020-2031) & (USD/Dose)
Figure 35. GlobalTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 36. GlobalTravelers Vaccines Revenue Market Share by End Users (2020-2031)
Figure 37. GlobalTravelers Vaccines Average Price by End Users (2020-2031) & (USD/Dose)
Figure 38. North AmericaTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 39. North AmericaTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 40. North AmericaTravelers Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 41. North AmericaTravelers Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 42. United StatesTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 43. CanadaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 44. MexicoTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 45. EuropeTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 46. EuropeTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 47. EuropeTravelers Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 48. EuropeTravelers Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 49. GermanyTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 50.FranceTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 51. United KingdomTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 52. RussiaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 53. ItalyTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 54. Asia-PacificTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 55. Asia-PacificTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 56. Asia-PacificTravelers Vaccines Sales Quantity Market Share by Region (2020-2031)
Figure 57. Asia-PacificTravelers Vaccines Consumption Value Market Share by Region (2020-2031)
Figure 58. ChinaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 59. JapanTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 60. South KoreaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 61. IndiaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 62. Southeast AsiaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 63. AustraliaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 64. South AmericaTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 65. South AmericaTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 66. South AmericaTravelers Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 67. South AmericaTravelers Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 68. BrazilTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 69. ArgentinaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 70. Middle East & AfricaTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 71. Middle East & AfricaTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 72. Middle East & AfricaTravelers Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 73. Middle East & AfricaTravelers Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 74.TurkeyTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 75. EgyptTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 76. Saudi ArabiaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 77. South AfricaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 78.Travelers Vaccines Market Drivers
Figure 79.Travelers Vaccines Market Restraints
Figure 80.Travelers Vaccines MarketTrends
Figure 81. PortersFiveForces Analysis
Figure 82. Manufacturing Cost Structure Analysis ofTravelers Vaccines in 2024
Figure 83. Manufacturing Process Analysis ofTravelers Vaccines
Figure 84.Travelers Vaccines Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1.Travelers Vaccines Picture
Figure 2. GlobalTravelers Vaccines Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. GlobalTravelers Vaccines Revenue Market Share byType in 2024
Figure 4. Meningococcal Vaccine Examples
Figure 5. Japanese Encephalitis Vaccine Examples
Figure 6. YellowFever Vaccine Examples
Figure 7. Hepatitis Vaccine Examples
Figure 8. Cholera Vaccine Examples
Figure 9. Other Examples
Figure 10. GlobalTravelers Vaccines Consumption Value by End Users, (USD Million), 2020 & 2024 & 2031
Figure 11. GlobalTravelers Vaccines Revenue Market Share by End Users in 2024
Figure 12.Tourists Examples
Figure 13. Students Examples
Figure 14. Workers Examples
Figure 15. Others Examples
Figure 16. GlobalTravelers Vaccines Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 17. GlobalTravelers Vaccines Consumption Value andForecast (2020-2031) & (USD Million)
Figure 18. GlobalTravelers Vaccines Sales Quantity (2020-2031) & (K Doses)
Figure 19. GlobalTravelers Vaccines Price (2020-2031) & (USD/Dose)
Figure 20. GlobalTravelers Vaccines Sales Quantity Market Share by Manufacturer in 2024
Figure 21. GlobalTravelers Vaccines Revenue Market Share by Manufacturer in 2024
Figure 22. Producer Shipments ofTravelers Vaccines by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 23.Top 3Travelers Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 24.Top 6Travelers Vaccines Manufacturer (Revenue) Market Share in 2024
Figure 25. GlobalTravelers Vaccines Sales Quantity Market Share by Region (2020-2031)
Figure 26. GlobalTravelers Vaccines Consumption Value Market Share by Region (2020-2031)
Figure 27. North AmericaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 28. EuropeTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 29. Asia-PacificTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 30. South AmericaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 31. Middle East & AfricaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 32. GlobalTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 33. GlobalTravelers Vaccines Consumption Value Market Share byType (2020-2031)
Figure 34. GlobalTravelers Vaccines Average Price byType (2020-2031) & (USD/Dose)
Figure 35. GlobalTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 36. GlobalTravelers Vaccines Revenue Market Share by End Users (2020-2031)
Figure 37. GlobalTravelers Vaccines Average Price by End Users (2020-2031) & (USD/Dose)
Figure 38. North AmericaTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 39. North AmericaTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 40. North AmericaTravelers Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 41. North AmericaTravelers Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 42. United StatesTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 43. CanadaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 44. MexicoTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 45. EuropeTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 46. EuropeTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 47. EuropeTravelers Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 48. EuropeTravelers Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 49. GermanyTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 50.FranceTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 51. United KingdomTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 52. RussiaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 53. ItalyTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 54. Asia-PacificTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 55. Asia-PacificTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 56. Asia-PacificTravelers Vaccines Sales Quantity Market Share by Region (2020-2031)
Figure 57. Asia-PacificTravelers Vaccines Consumption Value Market Share by Region (2020-2031)
Figure 58. ChinaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 59. JapanTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 60. South KoreaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 61. IndiaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 62. Southeast AsiaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 63. AustraliaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 64. South AmericaTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 65. South AmericaTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 66. South AmericaTravelers Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 67. South AmericaTravelers Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 68. BrazilTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 69. ArgentinaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 70. Middle East & AfricaTravelers Vaccines Sales Quantity Market Share byType (2020-2031)
Figure 71. Middle East & AfricaTravelers Vaccines Sales Quantity Market Share by End Users (2020-2031)
Figure 72. Middle East & AfricaTravelers Vaccines Sales Quantity Market Share by Country (2020-2031)
Figure 73. Middle East & AfricaTravelers Vaccines Consumption Value Market Share by Country (2020-2031)
Figure 74.TurkeyTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 75. EgyptTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 76. Saudi ArabiaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 77. South AfricaTravelers Vaccines Consumption Value (2020-2031) & (USD Million)
Figure 78.Travelers Vaccines Market Drivers
Figure 79.Travelers Vaccines Market Restraints
Figure 80.Travelers Vaccines MarketTrends
Figure 81. PortersFiveForces Analysis
Figure 82. Manufacturing Cost Structure Analysis ofTravelers Vaccines in 2024
Figure 83. Manufacturing Process Analysis ofTravelers Vaccines
Figure 84.Travelers Vaccines Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
More Publications
Global CNG Vehicles Market by Manufacturers, Countries, Type and Application, Forecast to 2022
US$ 3,480.00
February 2017
115 pages
Global Digital Single Lens Reflex Camera Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
January 2026
103 pages
Global Engine Mounts Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
136 pages
Global Road Marking Paint Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
140 pages
Global Airway Management Devices Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
January 2026
142 pages
